Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-03-04 7:26 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 3,011,900 6.3% | -385,773 (-11.35%) | View |
| 2020-03-04 4:21 pm Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 8,716,344 11.1% | -1,835,395 (-17.39%) | View |
| 2020-02-18 09:15 am Unchanged | 13G | KRYSTAL BIOTECH INC KRYS | ORBIMED ADVISORS LLC | 933,508 5.39% | 0 (Unchanged) | View |
| 2020-02-14 5:12 pm Purchase | 13G | KRYSTAL BIOTECH INC KRYS | ORBIMED ADVISORS LLC | 933,508 5.39% | 933,508 (New Position) | View |
| 2020-02-14 5:05 pm Sale | 13G | ARVINAS INC ARVN | ORBIMED ADVISORS LLC | 988,800 2.54% | -927,510 (-48.40%) | View |
| 2020-02-14 5:05 pm Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | ORBIMED ADVISORS LLC | 3,448,820 9.43% | 3,448,820 (New Position) | View |
| 2020-02-14 5:05 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | ORBIMED ADVISORS LLC | 849,254 4.59% | 849,254 (New Position) | View |
| 2020-02-14 5:05 pm Sale | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | ORBIMED ADVISORS LLC | 1,256,371 2.46% | -837,529 (-40.00%) | View |
| 2020-02-14 5:05 pm Sale | 13G | EHEALTH, INC. EHTH | ORBIMED ADVISORS LLC | 977,714 4.23% | -122,286 (-11.12%) | View |
| 2020-02-14 12:00 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | ORBIMED ADVISORS LLC | 2,865,524 9.89% | 700,000 (+32.32%) | View |
| 2020-02-14 12:00 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | ORBIMED ADVISORS LLC | 0 0% | -2,299,900 (Position Closed) | View |
| 2020-02-14 12:00 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 2,039,282 8.42% | 125,000 (+6.53%) | View |
| 2020-02-14 12:00 pm Sale | 13G | INSPIRE MED SYS INC INSP | ORBIMED ADVISORS LLC | 1,347,000 5.6% | -482,449 (-26.37%) | View |
| 2020-02-14 12:00 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | ORBIMED ADVISORS LLC | 0 0% | -2,063,837 (Position Closed) | View |
| 2020-02-14 12:00 pm Purchase | 13G | PROTHENA CORP PLC SHS PRTA | ORBIMED ADVISORS LLC | 2,288,439 5.74% | 2,288,439 (New Position) | View |
| 2020-02-14 12:00 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ORBIMED ADVISORS LLC | 3,944,090 6.11% | 3,944,090 (New Position) | View |
| 2020-02-10 4:39 pm Purchase | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | ORBIMED ADVISORS LLC | 4,067,564 10.7% | 4,067,564 (New Position) | View |
| 2020-02-05 4:39 pm Unchanged | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 10,551,739 13.5% | 0 (Unchanged) | View |
| 2020-02-05 4:36 pm Sale | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | ORBIMED ADVISORS LLC | 2,779,064 3.2% | -100,000 (-3.47%) | View |
| 2020-01-13 4:46 pm Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 10,551,739 15.3% | -840,490 (-7.38%) | View |